NCT04690348 2026-01-13
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
Clinical Trials
9 trialsNCT02507583 2025-05-07
Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma
Thomas Jefferson University
Phase 1 Completed
NCT03163368 2025-04-03
Dose Escalation Trial of Neoadjuvant Radiosurgery for the Treatment of Metastatic Brain Tumors
Cedars-Sinai Medical Center
Phase EARLY_PHASE1 Active not recruiting
NCT06831695 2025-02-18
Comparison of Surgical Outcomes of Craniotomy and Craniectomy in Posterior Fossa Lesions
University of Health Sciences Lahore
Phase NA Not yet recruiting
NCT00293423 2021-05-13
GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma
University of California, San Francisco
Phase 1/2 Completed
NCT00805376 2018-07-16
DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas
DNAtrix, Inc.
Phase 1 Completed
NCT01644955 2018-07-02
Carboplatin in Treating Patients With Recurrent High-Grade Gliomas
Ohio State University Comprehensive Cancer Center
Phase 1 Completed
NCT01413438 2017-07-02
Bevacizumab With or Without Surgery for Adult Glioblastomas
National Institutes of Health Clinical Center (CC)
Phase 2 Withdrawn
NCT00075166 2008-03-04
Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors
National Institutes of Health Clinical Center (CC)
Phase 4 Completed